Anonymous
Guest
Anonymous
Guest
Allergan, Inc. (AGN) Holder Pershing Square Files to Withdraw Prelim. Proxy
6:10 AM ET, 06/05/2014 - Street Insider
Allergan, Inc. (NYSE: AGN) holder filed to withdraw its preliminary proxy. The following letter was submitted to the U.S. SECershing Square Capital Management, L.P. 888 Seventh Avenue New York, New York 10019 June 4, 2014VIA EDGAR United States Securities and Exchange CommissionDivision of Corporate Finance100 F. Street, N.E.Washington, D.C. 20549Attn: Christina Chalk, Senior Special CounselOffice of Merger and Acquisitions Reershing Square Capital Management, L.P. Request to Withdraw Preliminary Proxy Statement on Schedule 14A File No. 001-10269Dear Ms. Chalkershing Square Capital Management, L.P., a Delaware limited partnership ( Pershing ), hereby respectfully requests the immediate withdrawal of the Preliminary Proxy Statement on Schedule 14A, originally filed by Pershing with the United States Securities and Exchange Commission (the Commission ) on May 13, 2014 (File No. 001-10269), along with any exhibits thereto (collectively referred to as the Proxy Statement ).In view of the fact that Pershing intends to attempt to call a special meeting of shareholders of Allergan, Inc. (the Special Meeting ), it no longer believes it is desirable to pursue the matters referred to in the Proxy Statement. Preliminary proxy materials with respect to the Special Meeting were filed by Pershing with the Commission on June 2, 2014. If you have any questions or comments regarding the foregoing request for withdrawal, please feel free to contact Pershing s counsel, Stephen Fraidin of Kirkland & Ellis LLP at (212) 446-4840. Very truly yours, Pershing Square Capital Management, L.P. /s/ William A. AckmanWilliam A. AckmanChief Executive Officer
-------------
WTF?
6:10 AM ET, 06/05/2014 - Street Insider
Allergan, Inc. (NYSE: AGN) holder filed to withdraw its preliminary proxy. The following letter was submitted to the U.S. SECershing Square Capital Management, L.P. 888 Seventh Avenue New York, New York 10019 June 4, 2014VIA EDGAR United States Securities and Exchange CommissionDivision of Corporate Finance100 F. Street, N.E.Washington, D.C. 20549Attn: Christina Chalk, Senior Special CounselOffice of Merger and Acquisitions Reershing Square Capital Management, L.P. Request to Withdraw Preliminary Proxy Statement on Schedule 14A File No. 001-10269Dear Ms. Chalkershing Square Capital Management, L.P., a Delaware limited partnership ( Pershing ), hereby respectfully requests the immediate withdrawal of the Preliminary Proxy Statement on Schedule 14A, originally filed by Pershing with the United States Securities and Exchange Commission (the Commission ) on May 13, 2014 (File No. 001-10269), along with any exhibits thereto (collectively referred to as the Proxy Statement ).In view of the fact that Pershing intends to attempt to call a special meeting of shareholders of Allergan, Inc. (the Special Meeting ), it no longer believes it is desirable to pursue the matters referred to in the Proxy Statement. Preliminary proxy materials with respect to the Special Meeting were filed by Pershing with the Commission on June 2, 2014. If you have any questions or comments regarding the foregoing request for withdrawal, please feel free to contact Pershing s counsel, Stephen Fraidin of Kirkland & Ellis LLP at (212) 446-4840. Very truly yours, Pershing Square Capital Management, L.P. /s/ William A. AckmanWilliam A. AckmanChief Executive Officer
-------------
WTF?